1 month Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug loomsMarketWatch

Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings that showed enough cash on its balance sheet to fund k…

Biotech · Earnings